为高风险人群优化疫苗保护
Thiago Cerqueira-Silva1, Manoel Barral-Netto2, Viviane Sampaio Boaventura3
1Laboratório de Medicina e Saúde Pública de Precisão, Fundação Oswaldo Cruz, Salvador, Brazil; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK; Instituto Nacional de Saúde Digital (INCT-DigiSaude), Salvador, Brazil.
Cell host & microbe
|November 13, 2025
概括
在弱势群体中接种疫苗的比例很低. 有针对性的沟通,更好的疫苗设计,包容性试验和现实研究可以改善这些人群的保护.
科学领域:
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
背景情况:
- 疫苗的有效性已被证明,但高风险人群的接种率仍然低于最佳水平.
- 诸如有限的获取,错误的信息和不够的临床试验数据等障碍阻碍了疫苗的采用.
- 脆弱人群需要量身定制的策略,以确保公平的疫苗接种和覆盖.
研究的目的:
- 确定改善高风险和脆弱人群接种疫苗的关键策略.
- 应对包括进入障碍,错误信息和疫苗研究数据缺口在内的挑战.
- 提出一个框架,以提高疫苗公平性和缩小疫苗保护差距.
主要方法:
- 讨论针对不同人群的有针对性的沟通策略.
- 探索优化的疫苗配方,以提高疫苗的有效性和发放.
- 综合性临床试验设计和现实世界的有效性研究的审查.
主要成果:
- 有针对性的沟通可以有效打击错误信息,提高对疫苗的信心.
- 优化的配方和包容性试验可以增加弱势群体的参与和适用性.
- 现实世界的证据对于在现实生活中证明疫苗的有效性至关重要.
结论:
- 通过量身定制的沟通解决访问障碍和错误信息至关重要.
- 包容性研究和优化疫苗开发对于弱势群体至关重要.
- 缩小保护差距需要一个多方面的方法,将研究,开发和有针对性的实施结合起来.
相关概念视频
Vaccinations
51.2K
Overview
51.2K
Cancer Vaccines
939
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
939
Development of Immunocompetence
778
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
778
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
Dosage Regimens: Designs and Approaches
248
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
248
Transmission-based Precautions II: Airborne and Protective Environment
1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K


